A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/06/2002	EP1253946A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
11/06/2002	EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002	EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity
11/06/2002	EP1253940A2 Low dose haptenized tumor cell and tumor cell extract immunotherapy
11/06/2002	EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002	EP1253938A2 Immunization of an individual against carcinoma and the preliminary stages thereof
11/06/2002	EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002	EP1253930A2 Method and compositions for treating hepatocellular cancer
11/06/2002	EP1063959B1 Sun-protection formulations active against herpes simplex viruses
11/06/2002	EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002	EP0865297B1 Vaccine compositions for intranasal administration comprising chitosan and use thereof
11/06/2002	EP0773959B1 Adrenergic receptor
11/06/2002	EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002	EP0689550B1 Antimicrobial peptides from bovine neutrophils
11/06/2002	CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof
11/06/2002	CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
11/06/2002	CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378553A Expression of immunogenic hepatitis B surface antigens in transgenic plants
11/06/2002	CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378458A Use of TGF-beta and growth factors in treatment and prevention of diseases of intestinal mucosa
11/06/2002	CN1377968A Malignant malarial parasite new antigen candidate gene pfMAg
11/06/2002	CN1377967A Malignant malarial parasite dynein gene
11/06/2002	CN1377894A Process for preparing egg yolk anti-cancer antibody and its use
11/06/2002	CN1377892A Cell factor gene modified antigen presentation cell/tumor cell conjugate, its preparatino and use
11/06/2002	CN1093881C Process for preparation of immunogens or diagnostic reagents, and method for obtaining immunogens or diagnostic reagents
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476201 Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
11/05/2002	US6476198 Multispecific and multivalent antigen-binding polypeptide molecules
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6475995 Oral delivery of nucleic acid vaccines by particulate complexes
11/05/2002	US6475983 Water-soluble polypeptides having a high affinity for α and β interferons
11/05/2002	US6475804 Composition and method for diagnosing auto-immune hepatitis
11/05/2002	US6475789 Human telomerase catalytic subunit: diagnostic and therapeutic methods
11/05/2002	US6475780 Alphavirus vectors for paramyxovirus vaccines
11/05/2002	US6475770 Processes for preparation of Marek's Disease using continuous mammalian cell lines
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475753 94 Human Secreted Proteins
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475741 Antiinflammatory agents
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475547 Immunoglobulin-rich milk, production and use thereof
11/05/2002	US6475492 Peptides and assays for the diagnosis of lyme disease
11/05/2002	US6475489 Synthesis of human virus antigens by yeast
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475483 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases
11/05/2002	US6475482 Genetically modified tumor-targeted bacteria with reduce virulence
11/05/2002	CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
10/2002
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002	WO2002086101A2 Core-glycosylated hcv envelope proteins
10/31/2002	WO2002086100A2 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086083A2 Methods of enhancing cell responsiveness
10/31/2002	WO2002086071A2 Cancer-testis antigens
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002	WO2002085947A1 Soluble protein from malaria parasite
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085933A1 Toll-like receptor 5 ligands and methods of use
10/31/2002	WO2002085932A2 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002	WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002	WO2002085446A2 Microprojection array immunization patch and method
10/31/2002	WO2002085434A1 Injection device for administering rna
10/31/2002	WO2002085411A1 Smallpox vaccine
10/31/2002	WO2002085409A2 Methods and compositions for inducing an immune response to an antigen
10/31/2002	WO2002085405A2 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF$g(a)
10/31/2002	WO2002085283A2 Vaccine against tuberculosis
10/31/2002	WO2002085093A2 Replikin peptides and uses thereof
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002	WO2002062197A3 Markers for disease susceptibility and targets for therapy
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002061048A3 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
10/31/2002	WO2002060477A9 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
10/31/2002	WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002	WO2002058628A3 Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands
10/31/2002	WO2002055713A3 58848, a human protein kinase family member and uses therefor
10/31/2002	WO2002055548A8 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/31/2002	WO2002053185A3 Anti-inflammatory use of polycationic compounds
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002032946A3 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
10/31/2002	WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002	WO2002020045A3 Vaccine against microbial pathogens
10/31/2002	WO2002014499A3 Claudin polypeptides
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002	WO2002008434A3 Bicistronic influenza comprising two genes in tandem
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2002000250A3 Hiv-1 vaccines and screening methods therefor
10/31/2002	WO2001061356A9 Her-2 binding antagonists
10/31/2002	WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2

1 ... 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 ... 1823